Lovastatin
Lovastatin comes in 23 pill versions in our database, in 3 strengths, from 9 manufacturers. Check the imprint to tell them apart.
Lovastatin pill images
10 mg 6 pills
- LU G01 Lovastatin 10 mg Green, oval, 6 mm Used for high cholesterol and high triglycerides
- 791 Lovastatin 10 mg White, round, 6 mm Used for high cholesterol and high triglycerides
- MP 532 Lovastatin 10 mg Orange, round, 8 mm Used for high cholesterol and high triglycerides
- CTI 141 Lovastatin 10 mg White, round, 6 mm Used for high cholesterol and high triglycerides
- R 633 Lovastatin 10 mg White, round, 8 mm Used for high cholesterol and high triglycerides
- 926 TEVA Lovastatin 10 mg Orange, round, 9 mm Used for high cholesterol and high triglycerides
20 mg 9 pills
- LU G02 Lovastatin 20 mg Green, round, 6 mm Used for high cholesterol and high triglycerides
- 792 Lovastatin 20 mg White, round, 8 mm Used for high cholesterol and high triglycerides
- MP 533 Lovastatin 20 mg Blue, round, 8 mm Used for high cholesterol and high triglycerides
- CTI 142 Lovastatin 20 mg White, round, 8 mm Used for high cholesterol and high triglycerides
- 634 Lovastatin 20 mg Pink, round, 8 mm Used for high cholesterol and high triglycerides
- R 634 Lovastatin 20 mg Pink, round, 8 mm Used for high cholesterol and high triglycerides
- E 72 Lovastatin 20 mg Blue, round, 8 mm Used for high cholesterol and high triglycerides
- 576 TEVA Lovastatin 20 mg Blue, round, 9 mm Used for high cholesterol and high triglycerides
- APO Lovastatin 20 mg Blue, octagon Used for high cholesterol and high triglycerides
40 mg 8 pills
- LU G03 Lovastatin 40 mg Green, round, 8 mm Used for high cholesterol and high triglycerides
- 793 Lovastatin 40 mg White, round, 10 mm Used for high cholesterol and high triglycerides
- MP 534 Lovastatin 40 mg Green, round, 8 mm Used for high cholesterol and high triglycerides
- CTI 143 Lovastatin 40 mg White, round, 10 mm Used for high cholesterol and high triglycerides
- R 635 Lovastatin 40 mg Yellow, round, 8 mm Used for high cholesterol and high triglycerides
- E 74 Lovastatin 40 mg Green, round, 8 mm Used for high cholesterol and high triglycerides
- 928 TEVA Lovastatin 40 mg Green, round, 9 mm Used for high cholesterol and high triglycerides
- APO Lovastatin 40 mg Green, octagon Used for high cholesterol and high triglycerides
What is Lovastatin used for?
Lovastatin is used for high cholesterol, high triglycerides and heart disease.
- Medicine type
- Statin (cholesterol medicine)
Official uses from the US prescribing label
Therapy with lovastatin should be a component of multiple risk factor intervention in those individuals with dyslipidemia at risk for atherosclerotic vascular disease. Lovastatin should be used in addition to a diet restricted in saturated fat and cholesterol as part of a treatment strategy to lower total-C and LDL-C to target levels when the response to diet and other nonpharmacological measures alone has been inadequate to reduce risk.
Primary Prevention of Coronary Heart Disease
In individuals without symptomatic cardiovascular disease, average to moderately elevated total-C and LDL-C, and below average HDL-C, lovastatin is indicated to reduce the risk of:
- Myocardial infarction
- Unstable angina
- Coronary revascularization procedures
(See CLINICAL PHARMACOLOGY, Clinical Studies.)
Coronary Heart Disease
Lovastatin is indicated to slow the progression of coronary atherosclerosis in patients with coronary heart disease as part of a treatment strategy to lower total-C and LDL-C to target levels.
Hypercholesterolemia
Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for artherosclerotic vascular disease due to hypercholesterolemia. Lovastatin is indicated as an adjunct to diet for the reduction of elevated total-C and LDL-C levels in patients with primary hypercholesterolemia (Types IIa and IIb 2), when the response to diet restricted in saturated fat and cholesterol and to other nonpharmacological measures alone has been inadequate.
Adolescent Patients with Heterozygous Familial Hypercholesterolemia
Lovastatin is indicated as an adjunct to diet to reduce total-C, LDL-C and apolipoprotein B levels in adolescent boys and girls who are at least one year post-menarche, 10 to 17 years of age, with heFH if after an adequate trial of diet therapy the following findings are present:
- LDL-C remains >189 mg/dL or
- LDL-C remains >160 mg/dL and:
- there is a positive family history of premature cardiovascular disease or
- two or more other CVD risk factors are present in the adolescent patient
General Recommendations
Prior to initiating therapy with lovastatin, secondary causes for hypercholesterolemia (e.g., poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be excluded, and a lipid profile performed to measure total-C, HDL-C, and TG. For patients with TG less than 400 mg/dL (<4.5 mmol/L), LDL-C can be estimated using the following equation:
LDL-C = total-C - [0.2 × (TG) + HDL-C]
For TG levels >400 mg/dL (>4.5 mmol/L), this equation is less accurate and LDL-C concentrations should be determined by ultracentrifugation. In hypertriglyceridemic patients, LDL-C may be low or normal despite elevated total-C. In such cases, lovastatin is not indicated.
The National Cholesterol Education Program (NCEP) Treatment Guidelines are summarized below:
After the LDL-C goal has been achieved, if the TG is still ≥200 mg/dL, non-HDL-C (total-C minus HDL-C) becomes a secondary target of therapy. Non-HDL-C goals are set 30 mg/dL higher than LDL-C goals for each risk category.
At the time of hospitalization for an acute coronary event, consideration can be given to initiating drug therapy at discharge if the LDL-C is ≥130 mg/dL (see NCEP Guidelines above).
Since the goal of treatment is to lower LDL-C, the NCEP recommends that LDL-C levels be used to initiate and assess treatment response. Only if LDL-C levels are not available, should the total-C be used to monitor therapy.
Although lovastatin may be useful to reduce elevated LDL-C levels in patients with combined hypercholesterolemia and hypertriglyceridemia where hypercholesterolemia is the major abnormality (Type IIb hyperlipoproteinemia), it has not been studied in conditions where the major abnormality is elevation of chylomicrons, VLDL or IDL (i.e., hyperlipoproteinemia types I, III, IV, or V). ***
The NCEP classification of cholesterol levels in pediatric patients with a familial history of hypercholesterolemia or premature cardiovascular disease is summarized below:
Children treated with lovastatin in adolescence should be re-evaluated in adulthood and appropriate changes made to their cholesterol-lowering regimen to achieve adult goals for LDL-C.
From the FDA-approved label on DailyMed (published Jul 24, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.